Optical Sensor for Photodynamic Detection of Oral Pathology
Sponsor: Livionex Inc.
Suspended
The PRMC committee has made the decision there is sufficient data to complete an analysis and publish findings.
This NA trial investigates Mouth Diseases and is currently suspended. Livionex Inc. leads this study, which shows 15 recorded versions since 2003 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Jan 2026 — Present [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Feb 2025 — Jan 2026 [monthly]
Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 10 earlier versions
-
Jan 2024 — May 2024 [monthly]
Recruiting NA
-
Dec 2022 — Jan 2024 [monthly]
Recruiting NA
-
Apr 2022 — Dec 2022 [monthly]
Recruiting NA
Phase: None → NA
-
Mar 2022 — Apr 2022 [monthly]
Recruiting
Status: Withdrawn → Recruiting
-
Jan 2021 — Mar 2022 [monthly]
Withdrawn
-
Jun 2018 — Jan 2021 [monthly]
Withdrawn
-
Apr 2018 — Jun 2018 [monthly]
Withdrawn
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Withdrawn NA
Status: Recruiting → Withdrawn
-
Jul 2017 — Feb 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Apr 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Livionex Inc.
- National Cancer Institute (NCI)
- National Institute for Biomedical Imaging and Bioengineering (NIBIB)
- National Institute of Dental and Craniofacial Research (NIDCR)
- Orahealth
- University of California, Irvine
For direct contact, visit the study record on ClinicalTrials.gov .